Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
TARSTarsus Pharmaceuticals(TARS) ZACKS·2024-08-09 07:07

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of 0.88pershareversustheZacksConsensusEstimateofalossof0.88 per share versus the Zacks Consensus Estimate of a loss of 0.98. This compares to loss of 1.17pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof10.201.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.20%. A quarter ago, it was expected that this company would post a loss of 1.15 per share when it actually produced a loss of $1.01, delivering a surprise of 12.17%.Over the last four quarters, the company ...